Forfivo
- Product NDC
- 52427-575
- 11-digit product format
- 524270575
- Labeler code
- 52427
- Product ID
- 52427-575_0b5f98f8-e57d-3636-bb45-78a1e564f6fc
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- bupropion hydrochloride
- Dosage form
- TABLET, FILM COATED, EXTENDED RELEASE
- Route
- ORAL
- Labeler
- Almatica Pharma Inc.
- Application
- NDA022497
- Marketing category
- NDA
- Marketing start
- 2017-05-15
- Marketing end
- 0000-00-00
- Substance
- BUPROPION HYDROCHLORIDE
- Active strength
- 450 mg/1
- Pharmacologic classes
- Aminoketone [EPC], Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 52427-575-30 | 52427057530 | 30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (52427-575-30) | 2017-05-15 | 0000-00-00 | No | No | Current |